Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 508

Similar articles for PubMed (Select 21552473)

1.
2.

Targeting photoreceptors via intravitreal delivery using novel, capsid-mutated AAV vectors.

Kay CN, Ryals RC, Aslanidi GV, Min SH, Ruan Q, Sun J, Dyka FM, Kasuga D, Ayala AE, Van Vliet K, Agbandje-McKenna M, Hauswirth WW, Boye SL, Boye SE.

PLoS One. 2013 Apr 26;8(4):e62097. doi: 10.1371/journal.pone.0062097. Print 2013. Erratum in: PLoS One. 2013;8(9). doi:10.1371/annotation/99ee1789-a658-4fb0-8593-40a40e9f344a.

3.

Self-complementary AAV5 vector facilitates quicker transgene expression in photoreceptor and retinal pigment epithelial cells of normal mouse.

Kong F, Li W, Li X, Zheng Q, Dai X, Zhou X, Boye SL, Hauswirth WW, Qu J, Pang JJ.

Exp Eye Res. 2010 May;90(5):546-54. doi: 10.1016/j.exer.2010.01.011. Epub 2010 Feb 4.

4.

Gene therapy following subretinal AAV5 vector delivery is not affected by a previous intravitreal AAV5 vector administration in the partner eye.

Li W, Kong F, Li X, Dai X, Liu X, Zheng Q, Wu R, Zhou X, Lü F, Chang B, Li Q, Hauswirth WW, Qu J, Pang JJ.

Mol Vis. 2009;15:267-75. Epub 2009 Feb 6.

5.

Tyrosine capsid-mutant AAV vectors for gene delivery to the canine retina from a subretinal or intravitreal approach.

Mowat FM, Gornik KR, Dinculescu A, Boye SL, Hauswirth WW, Petersen-Jones SM, Bartoe JT.

Gene Ther. 2014 Jan;21(1):96-105. doi: 10.1038/gt.2013.64. Epub 2013 Nov 14.

6.

Intraocular route of AAV2 vector administration defines humoral immune response and therapeutic potential.

Li Q, Miller R, Han PY, Pang J, Dinculescu A, Chiodo V, Hauswirth WW.

Mol Vis. 2008 Sep 24;14:1760-9.

7.

Optimized adeno-associated virus (AAV)-protein phosphatase-5 helper viruses for efficient liver transduction by single-stranded AAV vectors: therapeutic expression of factor IX at reduced vector doses.

Jayandharan GR, Zhong L, Sack BK, Rivers AE, Li M, Li B, Herzog RW, Srivastava A.

Hum Gene Ther. 2010 Mar;21(3):271-83. doi: 10.1089/hum.2009.100.

8.

Virus-mediated transduction of murine retina with adeno-associated virus: effects of viral capsid and genome size.

Yang GS, Schmidt M, Yan Z, Lindbloom JD, Harding TC, Donahue BA, Engelhardt JF, Kotin R, Davidson BL.

J Virol. 2002 Aug;76(15):7651-60.

9.

Evaluation of lateral spread of transgene expression following subretinal AAV-mediated gene delivery in dogs.

Bruewer AR, Mowat FM, Bartoe JT, Boye SL, Hauswirth WW, Petersen-Jones SM.

PLoS One. 2013;8(4):e60218. doi: 10.1371/journal.pone.0060218. Epub 2013 Apr 3.

10.

Exchange of surface proteins impacts on viral vector cellular specificity and transduction characteristics: the retina as a model.

Auricchio A, Kobinger G, Anand V, Hildinger M, O'Connor E, Maguire AM, Wilson JM, Bennett J.

Hum Mol Genet. 2001 Dec 15;10(26):3075-81.

11.

Assessment of ocular transduction using single-stranded and self-complementary recombinant adeno-associated virus serotype 2/8.

Natkunarajah M, Trittibach P, McIntosh J, Duran Y, Barker SE, Smith AJ, Nathwani AC, Ali RR.

Gene Ther. 2008 Mar;15(6):463-7. Epub 2007 Nov 15.

PMID:
18004402
12.

Real-time, noninvasive in vivo assessment of adeno-associated virus-mediated retinal transduction.

Bennett J, Duan D, Engelhardt JF, Maguire AM.

Invest Ophthalmol Vis Sci. 1997 Dec;38(13):2857-63.

PMID:
9418740
13.

High-efficiency transduction of the mouse retina by tyrosine-mutant AAV serotype vectors.

Petrs-Silva H, Dinculescu A, Li Q, Min SH, Chiodo V, Pang JJ, Zhong L, Zolotukhin S, Srivastava A, Lewin AS, Hauswirth WW.

Mol Ther. 2009 Mar;17(3):463-71. doi: 10.1038/mt.2008.269. Epub 2008 Dec 16.

14.

Ocular gene transfer with self-complementary AAV vectors.

Yokoi K, Kachi S, Zhang HS, Gregory PD, Spratt SK, Samulski RJ, Campochiaro PA.

Invest Ophthalmol Vis Sci. 2007 Jul;48(7):3324-8.

PMID:
17591905
15.

Enhanced transduction of mouse bone marrow-derived dendritic cells by repetitive infection with self-complementary adeno-associated virus 6 combined with immunostimulatory ligands.

Aldrich WA, Ren C, White AF, Zhou SZ, Kumar S, Jenkins CB, Shaw DR, Strong TV, Triozzi PL, Ponnazhagan S.

Gene Ther. 2006 Jan;13(1):29-39.

PMID:
16136165
16.

Differential internalization and nuclear uncoating of self-complementary adeno-associated virus pseudotype vectors as determinants of cardiac cell transduction.

Sipo I, Fechner H, Pinkert S, Suckau L, Wang X, Weger S, Poller W.

Gene Ther. 2007 Sep;14(18):1319-29. Epub 2007 Jul 5.

PMID:
17611587
17.

Comparison of the transduction efficiency of tyrosine-mutant adeno-associated virus serotype vectors in kidney.

Qi YF, Li QH, Shenoy V, Zingler M, Jun JY, Verma A, Katovich MJ, Raizada MK.

Clin Exp Pharmacol Physiol. 2013 Jan;40(1):53-5. doi: 10.1111/1440-1681.12037.

18.

AAV-mediated photoreceptor transduction of the pig cone-enriched retina.

Mussolino C, della Corte M, Rossi S, Viola F, Di Vicino U, Marrocco E, Neglia S, Doria M, Testa F, Giovannoni R, Crasta M, Giunti M, Villani E, Lavitrano M, Bacci ML, Ratiglia R, Simonelli F, Auricchio A, Surace EM.

Gene Ther. 2011 Jul;18(7):637-45. doi: 10.1038/gt.2011.3. Epub 2011 Mar 17.

19.

[Adeno-associated virus-mediated CD40 ligand transfer into human lung cancer cells].

Wu JQ, Zhao WH, Yin KS, Cheng YL.

Zhonghua Zhong Liu Za Zhi. 2007 Apr;29(4):253-7. Chinese.

PMID:
17760249
20.

Development and evaluation of the specificity of a cathepsin D proximal promoter in the eye.

Sutanto EN, Zhang D, Lai YK, Shen WY, Rakoczy EP.

Curr Eye Res. 2005 Jan;30(1):53-61.

PMID:
15875365
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk